Transgenic Group (TSE:2342) Total Equity: 円4,840 Mil (As of Mar. 2026)


TSE:2342 Transgenic Group Inc TSE:2342
60 GF Score
Price 円226.00
GF Value 円257.72
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Total Equity?

Transgenic Group TSE:2342 +5.61% 60 Total Equity is 円4,840 Mil as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 60/100 and a GF Value™ of 円257.72 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Transgenic Group's total equity for the quarter that ended in Mar. 2026 was 円4,840 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Transgenic Group Total Equity Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Total Equity Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,636.78 6,122.52 5,998.46 4,856.18 4,839.79

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,998.46 5,753.98 4,856.18 4,860.98 4,839.79
TSE:2342
60GF Score
Transgenic Group Inc TSE:2342
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Transgenic Group's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=9735.359-4895.571
=4,840

Transgenic Group's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=9735.359-4895.571
=4,840

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円4,840 Mil mean?
Transgenic Group (TSE:2342) has a Total Equity of 円4,840 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Transgenic Group and its competitors.
Is Transgenic Group's Total Equity too high?
Transgenic Group's current Total Equity is 円4,840 Mil. Overall, Transgenic Group has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Total Equity compare to VRTX and REGN?
Transgenic Group's Total Equity of 円4,840 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Transgenic Group and its competitors. Transgenic Group's current Total Equity is 円4,840 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.72, compared to a current price of 円226.00 — trading 12.3% below its estimated fair value. The current Total Equity is 円4,840 Mil. Transgenic Group's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Total Equity is 円4,840 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円226.00 is trading 12.3% below its estimated GF Value™ of 円257.72. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Total Equity: 円4,840 Mil
  • GF Value™: 円257.72 vs. price of 円226.00 (12.3% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
60GF Score

Get the complete analysis for TSE:2342

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円226.00
Price
円257.72
GF Value